Rifaximin Improves Gut Dysbiosis in Insulin Resistance and Type 2 Diabetes
NCT03758144
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
80
Enrollment
OTHER_GOV
Sponsor class
Conditions
Type2 Diabetes
Interventions
DRUG:
Rifaximin 200 MG
Sponsor
Zagazig University